Newsletter | January 27, 2025

01.27.25 -- BeiGene Details Its Approach To Expanding Oncology Trials Into Brazil

CLINICAL SITES

Feels Like Home: Designing Sites For Patient Comfort

Cold, stark, and purely functional, healthcare settings have long lacked the comfort and familiarity of home — until now. Uncommon Cures has used the science of hope to inspire its cozy, comfortable new trial site.

How Long Is Your RTSM Risk Mitigation List?

While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.

IQVIA GrantPlan Questions And Answers

IQVIA GrantPlan experts recently discussed how to use benchmark data to create fair market value budgets, given sky-rocketing inflation and attrition rates.

Breaking Free From Process Paralysis In Clinical Trials

Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.

Design And Execute Faster Trials With AI-Powered Insights

Explore how Intelligent Trials leverages the industry’s largest clinical dataset to accelerate enrollment, improve diversity, and provide real-time insights, ensuring efficient, data-driven trial success.

PATIENT CENTRICITY

BeiGene Details Its Approach To Expanding Oncology Trials Into Brazil

In this second article, BeiGene's Lígia Campos details its journey to setting roots in Brazil, sharing its beginnings there and highlighting its approach to study start-up and patient recruitment and enrollment.

Five Ways Sponsors And CROs Can Optimize Ophthalmic Clinical Trials

By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.

On The GO: Inside The World Of Clinical Trial Travel Coordination (USA)

Clinical trial Concierge Coordinators provide personalized support, addressing travel, logistics, and unique challenges for participants and caregivers, ensuring engagement, and trial success.

Treatment Benefits Of Wearable DHTs For Patients With Cancer Cachexia

Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during Pfizer's study into the benefits of using Ponsegromab for treating cancer cachexia.

PATIENT RECRUITMENT

Sick, Well, Or Somewhere In Between: Understanding The Patient Decision To Enroll In A Clinical Trial

Participating in clinical research involves profoundly personal and practical psychosocial considerations. Clinical Behavioral Healthcare Specialist Emily Epstein explains.

Putting Participants First To Meet Enrollment Goals

Increase enrollment and save costs by adopting patient- and site-centered methodologies that empower participants to contribute to groundbreaking clinical research on their own terms.

Enhancing Pediatric Learning and Retention

Discover an engaging and educational solution that transforms growth hormone deficiency treatment into a routine that helps children and parents manage daily therapy demands effectively.

Completing Recruitment In 4 Countries In A Study For ED

Uncover how this biotech was able to conduct a study evaluating a topical gel for the treatment of erectile dysfunction (ED) after successfully enrolling 100 male participants with diverse demographics.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical SitesPatient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: